BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 15005850)

  • 1. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
    Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
    J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
    Vahle JL; Zuehlke U; Schmidt A; Westmore M; Chen P; Sato M
    J Bone Miner Res; 2008 Dec; 23(12):2033-9. PubMed ID: 18684088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
    Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
    Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates.
    Seeherman HJ; Li XJ; Smith E; Parkington J; Li R; Wozney JM
    J Bone Joint Surg Am; 2013 Jan; 95(1):36-47. PubMed ID: 23283371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
    Iwamoto J; Seki A; Sato Y
    Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
    Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
    Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical Vibration Associated With Intermittent PTH Improves Bone Microarchitecture in Ovariectomized Rats.
    Campos JF; Mierzwa AGH; Freitas-Jesus M; Lazaretti-Castro M; Nonaka KO; Reginato RD
    J Clin Densitom; 2020; 23(3):511-519. PubMed ID: 30327242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys.
    Saito M; Marumo K; Kida Y; Ushiku C; Kato S; Takao-Kawabata R; Kuroda T
    Osteoporos Int; 2011 Aug; 22(8):2373-83. PubMed ID: 20959962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
    Fox J; Newman MK; Turner CH; Guldberg RE; Varela A; Smith SY
    Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Chandler H; Brooks DJ; Hattersley G; Bouxsein ML; Lanske B
    Osteoporos Int; 2019 Aug; 30(8):1607-1616. PubMed ID: 31053927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84.
    Miller MA; Bare SP; Recker RR; Smith SY; Fox J
    Bone; 2008 Jun; 42(6):1175-83. PubMed ID: 18387869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-times-weekly administration of teriparatide improves vertebral and peripheral bone density, microarchitecture, and mechanical properties without accelerating bone resorption in ovariectomized rats.
    Takao-Kawabata R; Isogai Y; Takakura A; Shimazu Y; Sugimoto E; Nakazono O; Ikegaki I; Kuriyama H; Tanaka S; Oda H; Ishizuya T
    Calcif Tissue Int; 2015 Aug; 97(2):156-68. PubMed ID: 25911187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological Effects of the Combined Administration of Eldecalcitol and a Parathyroid Hormone in the Metaphyseal Trabeculae of Ovariectomized Rats.
    Hasegawa T; Yamamoto T; Sakai S; Miyamoto Y; Hongo H; Qiu Z; Abe M; Takeda S; Oda K; de Freitas PHL; Li M; Endo K; Amizuka N
    J Histochem Cytochem; 2019 Mar; 67(3):169-184. PubMed ID: 30311820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent administration of human parathyroid hormone (1-34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora.
    Ohkawa Y; Tokunaga K; Endo N
    J Orthop Sci; 2008 Nov; 13(6):533-42. PubMed ID: 19089541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.